Abiopharma

🔍 GIC Private Ltd (Executive)

Company: Medline Inc. (MDLN)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 1,500,000 shares of Class A Common Stock at $35.8 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 22,902,482.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 100,000 shares of Class A Common Stock at $35.8 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 22,802,482.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-13 | Code: H | nature_of_ownership: Hux Investment Pte. Ltd. | shares_owned_after: 91,555,447.00 | Footnotes: F1

Footnotes:

• F1: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
• F2: These securities are owned directly by Hux. Hux shares the power to vote and the power to dispose of these securities with GIC Special Investments Pte. Ltd. ("GIC SI") and GIC (with Hux and GIC SI, each a "Reporting Person"), both of which are private limited companies incorporated in Singapore. GIC SI is wholly owned by GIC and is the private equity investment arm of GIC. GIC is wholly owned by the Government of Singapore and was set up with the sole purpose of managing Singapore's foreign reserves. The Government of Singapore disclaims beneficial ownership of these securities.